Aug 2026· Frontiers in Food Science and Technology· Vol 6· 0 citations· 153 references
Abstract
Polyphenols are among the most versatile secondary metabolites of plants, with significant therapeutic potential, including anti-inflammatory, cardioprotective, and antioxidant properties. However, limited bioavailability impedes their clinical application. These improvements have led to the use of synthetic stabilizers, toxic solvents, and high-energy inputs, raising concerns about the sustainability, scalability, and environmental impact of these techniques. The bioavailability of polyphenolic bioactives is an emerging area of interest, and green strategies have been developed to address it. Recently, a series of carrier-free delivery systems have also been developed, such as edible colloidal architectures, biopolymer nanoparticles, self-assembled nanostructures, and protein/polysaccharide conjugate nanocarriers, which can enhance solubility, stability, gastrointestinal performance, and release profiles. This review offers a critical analysis of approaches to improve polyphenol bioavailability, as well as recent developments in sustainable formulation design, physicochemical characterization, and translational considerations. This review critically examines the potential, limitations, and future research directions for developing safe, scalable, and environmentally friendly polyphenol delivery systems for therapeutic applications.
Phytochemicals have gained remarkable attention because of their broad-spectrum therapeutic activities, including antioxidant, anti-inflammatory, antimicrobial, neuroprotective, and anticancer effects. Despite their pharmacological potential, the clinical translation of many phytochemicals remains limited due to poor a...
G. Pramoda, Rahul Shukla· Chemical Communications· 0 citations
An overview of nanotechnology-enabled flavonoid delivery covering polymeric and lipid nanoencapsulates, nanoemulsions, nanocrystals, liposomes, solid lipid nanoparticles, SLNPs, nanostructured lipid carriers, metallic NPs, and nanofibers has been assessed and analyzed.
Sayed M. Saleh, Riaz A. Khan, L. Aroua et al.· International Journal of Nan...· 0 citations
Plant-derived bioactives offer diverse pharmacological activities, but their development is often limited by poor aqueous solubility, instability, rapid metabolism, and low tissue exposure. This review examines delivery platforms used to address these constraints, including liposomes, solid lipid nanoparticles, nanostr...
Saima Jan, Gulam Rabbani, Arif Tasleem Jan et al.· Pharmaceutics· 0 citations
A promising approach to cancer therapy is presented by integrating polyphenol-based nanoformulations into hybrid nanoformulations, addressing key limitations of conventional polyphenol delivery and thereby enhancing their anticancer potential through multiple molecular pathways.
Saloni Bhandari, Bhuvanesh Baniya, Supriya Singh et al.· Current pharmaceutical desig...· 0 citations
Nanocarrier-mediated delivery has shown improved pharmacokinetics, enhanced in vivo efficacy, and greater potential for synergistic combination therapies, and greater potential for synergistic combination therapies.
S. Garg, Atulika Sharma, Jeena Gupta· BioNanoScience· 0 citations
Gold nanop articles (AuNPs) have garnered significant attention in biomedical research owing to their unique physicochemical properties, including biocompatibility, tunable stability, and versatile surface chemistries. However, conventional physical and chemical synthesis methods often depend on hazardous reagents and...
Hansa Gul, Nasir Assad, Z. Nasreen et al.· Discover Nano· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.